Six key facts about the market for insulins


The insulin market is commonly mischaracterized as lacking competition. In fact, robust competition among biopharmaceutical companies that produce insulin results in increasing levels of discounts and rebates that have constrained prices in recent years. Unfortunately, patients typically do not benefit from the fruits of the competitive marketplace because the price they pay at the pharmacy – set by their insurer – is tied to the undiscounted list price.